Corsie Cardiopet Ramipril 5mg Tablets for Dogs and Cats
Inclusive of all taxes
Product Details
| Product type | Oral Tablets |
| Volume / Quantity | Pack of 30 Tablets (Typically sold as 3 strips of 10 tablets per box) |
| Target Species | Canines and Felines (Dogs and cats diagnosed with structural cardiac strain, chronic hypertension, or protein-losing nephropathies) |
| Common Use Case | Long-term therapeutic control of mild to moderate cardiac insufficiency and Congestive Heart Failure (CHF); clinical management of systemic hypertension; reduction of progressive ventricular hypertrophy and myocardial tissue remodeling; and renoprotective management of Chronic Renal Failure (CRF) to control proteinuria and preserve baseline kidney function. |
Corise Cardiopet Ramipril 5mg is a prescription-only veterinary cardiovascular and renal medication formulated for dogs and cats. The active pharmaceutical ingredient, Ramipril (5mg), is a highly effective, long-acting Angiotensin-Converting Enzyme (ACE) inhibitor. Upon oral administration, Ramipril acts as a prodrug that is quickly bio-transformed by the liver into its highly potent active metabolite, ramiprilat. This active compound suppresses the renin-angiotensin-aldosterone system (RAAS) by preventing the conversion of angiotensin I into angiotensin II, which is a powerful blood vessel constrictor.
The resulting systemic vasodilation effectively lowers peripheral vascular resistance and decreases blood pressure without causing dangerous spikes in heart rate. By diminishing the preload and afterload (the physical workload) on compromised heart chambers, Cardiopet Ramipril 5mg significantly curbs left ventricular mass enlargement, tones down structural myocardial remodeling, and mitigates myocardial fibrosis in animals dealing with congestive heart failure (CHF) and valvular pathologies. Beyond specialized cardiac management, it offers critical renoprotective mechanisms for companion animals. By decreasing intraglomerular capillary pressure, it aids in managing Chronic Renal Failure (CRF) and reducing harmful protein loss through urine (proteinuria). Administered orally once daily, it visibly minimizes clinical symptoms like persistent coughing, respiratory distress, and lethargy, substantially boosting stamina and baseline comfort.